BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND PRKACA, MGC48865, 5566, ENSG00000072062, P17612, PKACA, MGC102831 AND Diagnosis
7 results:

  • 1. Clinical Characteristics and Long-Term Outcomes of Adrenal Tumors in Children and Adolescents.
    Kim JH; Choi Y; Hwang S; Yoon JH; Kim GH; Yoo HW; Choi JH
    Exp Clin Endocrinol Diabetes; 2023 Oct; 131(10):515-522. PubMed ID: 37437600
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype.
    Mattiolo P; Hong SM; Paolino G; Rusev BC; Marchegiani G; Salvia R; Andrianello S; Capelli P; Piccoli P; Parolini C; Scarpa A; Lawlor RT; Luchini C
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806726
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genomics of benign adrenocortical tumors.
    Jouinot A; Armignacco R; AssiƩ G
    J Steroid Biochem Mol Biol; 2019 Oct; 193():105414. PubMed ID: 31207362
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Non-androgen secreting adrenocortical carcinoma in preadolescence: a case report and literature review.
    Narumi H; Hasegawa S; Waki K; Fukuda K; Ohnishi Y; Ichimura T; Fujimoto Y; Katsura S; Kawano H; Ikeda E; Okada S; Ohga S
    J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1313-1317. PubMed ID: 27771624
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Steroidogenic Acute Regulatory Protein Overexpression Correlates with Protein Kinase A Activation in Adrenocortical Adenoma.
    Zhou W; Wu L; Xie J; Su T; Jiang L; Jiang Y; Cao Y; Liu J; Ning G; Wang W
    PLoS One; 2016; 11(9):e0162606. PubMed ID: 27606678
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Double adrenocortical adenomas harboring independent KCNJ5 and prkaca somatic mutations.
    Nanba K; Omata K; Tomlins SA; Giordano TJ; Hammer GD; Rainey WE; Else T
    Eur J Endocrinol; 2016 Aug; 175(2):K1-6. PubMed ID: 27165862
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.
    Sato Y; Maekawa S; Ishii R; Sanada M; Morikawa T; Shiraishi Y; Yoshida K; Nagata Y; Sato-Otsubo A; Yoshizato T; Suzuki H; Shiozawa Y; Kataoka K; Kon A; Aoki K; Chiba K; Tanaka H; Kume H; Miyano S; Fukayama M; Nureki O; Homma Y; Ogawa S
    Science; 2014 May; 344(6186):917-20. PubMed ID: 24855271
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.